Literature DB >> 28848867

COPD Overlap Syndromes: Asthma and Beyond.

Allison A Lambert1, Mark T Dransfield2.   

Abstract

This article serves as a CME-available, enduring material summary of the following COPD9USApresentations: "COPD and Asthma" Presenter: Prescott Woodruff, MD, MPH "COPD and Lung Cancer" Presenter: William Bulman, MD "COPD and Bronchiectasis" Presenter: Jeremy Clain, MD "COPD and Interstitial Lung Disease" Presenter GeorgeWashko, MD.

Entities:  

Keywords:  asthma; bronchiectasis; copd; interstitial lung disease; lung cancer; overlap

Year:  2016        PMID： 28848867      PMCID： PMC5559127          DOI： 10.15326/jcopdf.3.1.2015.0176

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


  53 in total

1.  Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends.

Authors:  Marc J Licker; Igor Widikker; John Robert; Jean-George Frey; Anastase Spiliopoulos; Christoph Ellenberger; Alexandre Schweizer; Jean-Marie Tschopp
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

2.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

Review 3.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

4.  Airways obstruction and the risk for lung cancer.

Authors:  M S Tockman; N R Anthonisen; E C Wright; M G Donithan
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

Review 5.  Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes.

Authors:  Stacy Raviv; Keenan A Hawkins; Malcolm M DeCamp; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

6.  Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.

Authors:  R Leigh; M M M Pizzichini; M M Morris; F Maltais; F E Hargreave; E Pizzichini
Journal:  Eur Respir J       Date:  2006-01-30       Impact factor: 16.671

Review 7.  Smoking cessation in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Robert P Murray
Journal:  Respir Med       Date:  2009-03-14       Impact factor: 3.415

8.  Complex chronic comorbidities of COPD.

Authors:  L M Fabbri; F Luppi; B Beghé; K F Rabe
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

9.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

10.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.

Authors:  D M Skillrud; K P Offord; R D Miller
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391
View more
  4 in total

1.  Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.

Authors:  Yin Li; Jie Gu; Fengkai Xu; Qiaoliang Zhu; Di Ge; Chunlai Lu
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

2.  Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.

Authors:  Yusuke Takanashi; Kazuhito Funai; Fumihiro Eto; Kiyomichi Mizuno; Akikazu Kawase; Hong Tao; Takuya Kitamoto; Yutaka Takahashi; Haruhiko Sugimura; Mitsutoshi Setou; Tomoaki Kahyo; Norihiko Shiiya
Journal:  BMC Cancer       Date:  2021-11-17       Impact factor: 4.430

Review 3.  Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective.

Authors:  Diana E Amariei; Neal Dodia; Janaki Deepak; Stella E Hines; Jeffrey R Galvin; Sergei P Atamas; Nevins W Todd
Journal:  Medicina (Kaunas)       Date:  2019-09-10       Impact factor: 2.430

4.  Risk of atrial fibrillation in patients with pneumoconiosis: A nationwide study in Taiwan.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  Clin Cardiol       Date:  2019-11-29       Impact factor: 2.882
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.